通过IMT1准POLRMT可以抑制结直肠癌细胞的生长
Hao Wang1,2, Yuxin Liu3, Xing-Sheng Lu4
1Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Cell death & disease
|September 3, 2024
概括
一种新型的抑制剂,IMT1,向线粒体RNA聚合酶 (POLRMT),以对抗结直肠癌 (CRC). 通过破坏线粒体功能和诱导亡,IMT1有效地减少CRC细胞生长,迁移和转移.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体RNA聚合酶 (POLRMT) 在结直肠癌 (CRC) 细胞和组织中过度表达.
- 过度表达POLRMT与增加的CRC细胞增殖和迁移有关.
研究的目的:
- 为了研究IMT1,一种新型POLRMT抑制剂的抗CRC潜力.
- 阐明IMT1抗癌作用背后的机制.
主要方法:
- 单细胞RNA测序以评估POLRMT的表达.
- 在体外测试中使用原始和不朽化CRC细胞来评估IMT1对细胞活力,增殖,细胞亡和迁移的影响.
- 使用老鼠异种移植模型进行体内研究,以评估IMT1在抑制瘤生长和转移方面的有效性.
- 西方模糊分析信号通路,包括Akt1-S6K1和Akt-mTOR.
主要成果:
- IMT1显著抑制了CRC细胞殖民地形成,活力,增殖,细胞周期进展和迁移.
- 通过破坏线粒体功能,IMT1诱导了细胞亡和细胞死亡,导致脱极化,氧化损伤和降低ATP水平.
- 沉默POLRMT模仿IMT1的影响,而POLRMT过度表达促进了CRC细胞的生长和迁移.
- 在体内,IMT1治疗抑制了瘤生长和肺转移,并抑制了Akt-mTOR信号传输.
结论:
- IMT1通过特别抑制POLRMT,表现出强大的抗CRC活性.
- 准POLRMT破坏了线粒体功能,并抑制了促进癌症的关键信号通路,为CRC提供了一个有前途的治疗策略.
更多相关视频
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
10.0K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K